BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11472349)

  • 1. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.
    Noguchi T; Ikeda K; Yamamoto K; Yoshida I; Ashiba A; Tsuchiyama J; Shinagawa K; Yoshino T; Takata M; Harada M
    Br J Haematol; 2001 Jul; 114(1):84-92. PubMed ID: 11472349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.
    Kenney JL; Guinness ME; Curiel T; Lacy J
    Blood; 1998 Sep; 92(5):1721-7. PubMed ID: 9716601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents.
    Kenney JL; Guinness ME; Reiss M; Lacy J
    Int J Cancer; 2001 Jan; 91(1):89-98. PubMed ID: 11149426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma.
    Sun L; Zhao Y; Shi H; Ma C; Wei L
    Oncol Rep; 2015 May; 33(5):2253-60. PubMed ID: 25760809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.
    Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
    Int J Cancer; 2002 Jun; 99(5):705-12. PubMed ID: 12115504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
    Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.
    Takahara M; Kis LL; Nagy N; Liu A; Harabuchi Y; Klein G; Klein E
    Int J Cancer; 2006 Dec; 119(12):2775-83. PubMed ID: 17013900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
    J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
    Martin JM; Veis D; Korsmeyer SJ; Sugden B
    J Virol; 1993 Sep; 67(9):5269-78. PubMed ID: 8394449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells.
    Lu JJ; Chen JY; Hsu TY; Yu WC; Su IJ; Yang CS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():2975-85. PubMed ID: 9367385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
    Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
    Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    D'Souza B; Rowe M; Walls D
    J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME; Kenney JL; Reiss M; Lacy J
    Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
    Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
    Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A.
    Uno M; Tsuchiyama J; Moriwaki A; Noguchi T; Mizoguchi K; Ogino T; Yoshino T; Okada S; Harada M
    Br J Haematol; 2001 Jun; 113(4):1009-14. PubMed ID: 11442496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
    Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
    Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
    Kuo TT; Shih LY; Tsang NM
    Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.